190 related articles for article (PubMed ID: 8582396)
1. Acylcarnitines in intermediary metabolism.
Sewell AC; Böhles HJ
Eur J Pediatr; 1995 Nov; 154(11):871-7. PubMed ID: 8582396
[TBL] [Abstract][Full Text] [Related]
2. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
Fuda F; Narayan SB; Squires RH; Bennett MJ
Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
4. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
[TBL] [Abstract][Full Text] [Related]
5. Acylcarnitines participate in developmental processes associated to lipid metabolism in plants.
Nguyen PJ; Rippa S; Rossez Y; Perrin Y
Planta; 2016 Apr; 243(4):1011-22. PubMed ID: 26748916
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
7. Acylcarnitines: role in brain.
Jones LL; McDonald DA; Borum PR
Prog Lipid Res; 2010 Jan; 49(1):61-75. PubMed ID: 19720082
[TBL] [Abstract][Full Text] [Related]
8. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
Reuter SE; Evans AM
Clin Pharmacokinet; 2012 Sep; 51(9):553-72. PubMed ID: 22804748
[TBL] [Abstract][Full Text] [Related]
9. Acylcarnitines--old actors auditioning for new roles in metabolic physiology.
McCoin CS; Knotts TA; Adams SH
Nat Rev Endocrinol; 2015 Oct; 11(10):617-25. PubMed ID: 26303601
[TBL] [Abstract][Full Text] [Related]
10. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism.
Violante S; Ijlst L; Ruiter J; Koster J; van Lenthe H; Duran M; de Almeida IT; Wanders RJ; Houten SM; Ventura FV
Biochim Biophys Acta; 2013 Jun; 1832(6):773-9. PubMed ID: 23485643
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of unsaturated acylcarnitine molecular species during acute myocardial ischemia: metabolic compartmentalization of products of fatty acyl chain elongation in the acylcarnitine pool.
Ford DA; Han X; Horner CC; Gross RW
Biochemistry; 1996 Jun; 35(24):7903-9. PubMed ID: 8672492
[TBL] [Abstract][Full Text] [Related]
13. Carnitine and acylcarnitine levels of human peripheral blood lymphocytes and mononuclear phagocytes.
Cress AP; Fraker PJ; Bieber LL
Biochim Biophys Acta; 1989 Aug; 992(2):135-9. PubMed ID: 2474331
[TBL] [Abstract][Full Text] [Related]
14. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
[TBL] [Abstract][Full Text] [Related]
15. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
16. Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors.
Wolf M; Chen S; Zhao X; Scheler M; Irmler M; Staiger H; Beckers J; de Angelis MH; Fritsche A; Häring HU; Schleicher ED; Xu G; Lehmann R; Weigert C
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1137-42. PubMed ID: 23633211
[TBL] [Abstract][Full Text] [Related]
17. Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria.
Liepinsh E; Makrecka-Kuka M; Volska K; Kuka J; Makarova E; Antone U; Sevostjanovs E; Vilskersts R; Strods A; Tars K; Dambrova M
Biochem J; 2016 May; 473(9):1191-202. PubMed ID: 26936967
[TBL] [Abstract][Full Text] [Related]
18. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency.
Fingerhut R; Ensenauer R; Röschinger W; Arnecke R; Olgemöller B; Roscher AA
Anal Chem; 2009 May; 81(9):3571-5. PubMed ID: 19323528
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
20. Role of carnitine-dependent metabolic pathways in heart disease without primary ischemia.
Bremer J; Hokland B
Z Kardiol; 1987; 76 Suppl 5():9-13. PubMed ID: 3324530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
